Viekira

Generic name: Dasabuvir, Ombitasvir, Paritaprevir, And Ritonavir
Drug class: Antiviral combinations

Usage of Viekira

Viekira is an antiviral medicine containing a combination of dasabuvir, ombitasvir, paritaprevir, and ritonavir. Dasabuvir, ombitasvir, paritaprevir, and ritonavir are antiviral medicines that prevent the hepatitis C virus (HCV) from multiplying in your body.

Viekira is used to treat chronic hepatitis C in adults. It is sometimes given in combination with another antiviral medicine called ribavirin.

Viekira treats specific genotypes of hepatitis C, and only in certain people. Use only the medications prescribed for you. Do not share your medicine with other people.

Viekira is sometimes used in people who also have HIV. This medicine is not a treatment for HIV or AIDS.

Viekira side effects

Get emergency medical help if you have signs of an allergic reaction to Viekira: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have new or worsening symptoms such as:

confusion;

loss of appetite, upper stomach pain;

dark urine, clay-colored stools; or

jaundice (yellowing of the skin or eyes).

Common Viekira side effects may include:

nausea;

itching, skin rash or redness;

sleep problems (insomnia); or

feeling weak or tired.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Viekira

You should not use Viekira if you are allergic to dasabuvir, ombitasvir, paritaprevir, or ritonavir, or if:

you have moderate to severe liver disease; or

you have ever had a severe skin rash after taking ritonavir (Norvir).

If you take Viekira with ribavirin: There may be other reasons you should not take this combination treatment. Tell your doctor about all your medical conditions.

Many drugs can interact and cause dangerous effects. Some drugs should not be used together with dasabuvir, ombitasvir, paritaprevir, and ritonavir. Your doctor may change your treatment plan if you also use:

alfuzosin;

apalutamide;

colchicine;

dronedarone;

efavirenz (Atripla, Sustiva, Symfi);

ranolazine;

rifampin;

sildenafil (Revatio), when taken for pulmonary artery hypertension (PAH);

St. John's wort;

oral midazolam (Versed), or triazolam;

anti-psychotic medicine - lurasidone, pimozide;

birth control pills or patches - Lo Loestrin FE, Norinyl, Ortho Tri-Cyclen Lo, Ortho Evra, and others;

hormone replacement therapy such as Fem HRT;

a vaginal ring such as NuvaRing;

cholesterol-lowering medicine - atorvastatin, gemfibrozil, lomitapide, lovastatin, simvastatin (Zocor, Vytorin, Simcor);

an immunosuppressant - everolimus, sirolimus, tacrolimus;

ergot medicine - dihydroergotamine, ergotamine, methylergonovine; or

seizure medicine - Carbamazepine, phenytoin, phenobarbital.

Before you start taking Viekira, you must stop using medicine that contains ethinyl estradiol. This includes certain birth control pills or hormone replacement medicines. Ask your doctor about using non-hormonal birth control (condom, diaphragm with spermicide) to prevent pregnancy while taking Viekira and for 2 weeks after your treatment ends.

To make sure this medicine is safe for you, tell your doctor if you have ever had:

liver problems other than hepatitis C (such as cirrhosis or hepatitis B);

HIV (human immunodeficiency virus);

a liver transplant; or

if you use a blood thinner (warfarin, Coumadin, Jantoven) and you have routine "INR" or prothrombin time tests.

It is not known whether Viekira will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Viekira is sometimes used in combination with ribavirin. Ribavirin can cause birth defects or death in an unborn baby.

If you are a woman, do not use ribavirin if you are pregnant. You may need to have a negative pregnancy test before taking ribavirin and every month during your treatment.

If you are a man, do not use ribavirin if your sexual partner is pregnant. An unborn baby could be harmed if you have sex with a pregnant woman while you are taking ribavirin.

While taking Viekira with ribavirin, use at least 2 effective forms of birth control to prevent pregnancy, whether you are a man or a woman. Ribavirin use by either parent may cause birth defects.

Keep using 2 forms of birth control for at least 6 months after your last dose of ribavirin. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using ribavirin.

It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

Relate drugs

How to use Viekira

Usual Adult Dose for Chronic Hepatitis C:

Viekira Pak: -Dasabuvir: 250 mg orally twice a day (morning and evening) -Ombitasvir/paritaprevir/ritonavir fixed-dose combination tablet: 2 tablets orally once a day (in the morning) Extended-release tablets (fixed-dose combination): 3 tablets orally once a day Recommended Regimen and Duration of Therapy: -Genotype 1a, without cirrhosis: Viekira Pak plus ribavirin OR extended-release tablets plus ribavirin for 12 weeks -Genotype 1a, with compensated cirrhosis (Child-Pugh A): Viekira Pak plus ribavirin OR extended-release tablets plus ribavirin for 24 weeks ---For some patients based on prior treatment history: May consider Viekira Pak plus ribavirin OR extended-release tablets plus ribavirin for 12 weeks -Genotype 1b, with or without compensated cirrhosis (Child-Pugh A): Viekira Pak OR extended-release tablets for 12 weeks -Liver transplant recipients with normal liver function and mild fibrosis (Metavir fibrosis score 2 or lower), regardless of HCV genotype 1 subtype: Viekira Pak plus ribavirin OR extended-release tablets plus ribavirin for 24 weeks Comments: -Recommended for therapy-naive or interferon-experienced patients, including those with HCV/HIV-1 coinfection -The dosing recommendations for genotype 1a should be followed for patients with unknown genotype 1 subtype or with mixed genotype 1 infection. -The manufacturer product information should be consulted for ribavirin dosing recommendations (if applicable), regarding dosing of concomitant HIV-1 antiviral drugs in HCV/HIV-1-coinfected patients, and regarding use with calcineurin inhibitors in liver transplant recipients. -The manufacturer product information for ribavirin should be consulted regarding dose adjustments (if applicable). Uses: For the treatment of chronic HCV infection -In genotype 1b-infected patients without cirrhosis or with compensated cirrhosis -In combination with ribavirin: In genotype 1a-infected patients without cirrhosis or with compensated cirrhosis

Warnings

If you have ever had hepatitis B, Viekira can cause this condition to come back or get worse. You will need frequent blood tests to check your liver function.

Before you start taking Viekira, you must stop using certain birth control pills or hormone replacement medicines. Ask your doctor about using non-hormonal birth control to prevent pregnancy.

What other drugs will affect Viekira

When you start or stop taking Viekira, your doctor may need to adjust the doses of any other medicines you take on a regular basis.

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Many drugs can interact with Viekira, and some drugs should not be used together. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.